
Laboratory Corporation of America Holdings LH
$ 251.35
0.14%
Quarterly report 2025-Q3
added 10-31-2025
Country |
|
IPO year |
- |
Industry |
Diagnostics research |
Stock Exchange |
NYSESPB |
Shares |
83.9 M |
Market Cap[1] |
$ 21.1 B |
EBITDA (LTM) |
$ 1.74 B |
P/E (LTM) |
23.82 |
P/S (LTM) |
1.54 |
EPS (LTM) |
10.55 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Brainsway Ltd.
BWAY
|
$ 19.14 | 0.63 % | $ 99.4 M | Nasdaq Global Select Market | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Burning Rock Biotech Limited
BNR
|
$ 19.97 | -4.84 % | $ 215 M | Nasdaq Global Market | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
BioNano Genomics
BNGO
|
$ 1.59 | 3.59 % | $ 2.02 M | Nasdaq Capital Market,SPB | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
Co-Diagnostics
CODX
|
$ 5.64 | 11.51 % | $ 166 M | Nasdaq Capital Market | ||
|
Castle Biosciences
CSTL
|
$ 38.43 | -1.21 % | $ 1.07 B | Nasdaq Global Market,SPB | ||
|
Danaher Corporation
DHR
|
$ 230.25 | 0.53 % | $ 168 B | NYSE,SPB | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
DarioHealth Corp.
DRIO
|
$ 10.5 | -7.73 % | $ 298 M | Nasdaq Capital Market | ||
|
DexCom
DXCM
|
$ 66.65 | 0.42 % | $ 25.7 B | Nasdaq Global Select Market,SPB | ||
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Exact Sciences Corporation
EXAS
|
$ 101.69 | 0.13 % | $ 18.8 B | Nasdaq Capital Market,SPB | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
Fulgent Genetics
FLGT
|
$ 25.65 | -2.37 % | $ 776 M | Nasdaq Global Market | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
CareDx, Inc
CDNA
|
$ 19.11 | 1.43 % | $ 1.03 B | Nasdaq Global Market,SPB | ||
|
Celcuity
CELC
|
$ 100.55 | 0.81 % | $ 3.97 B | Nasdaq Global Select Market | ||
|
Anixa Biosciences
ANIX
|
$ 3.14 | 0.64 % | $ 100 K | Nasdaq Capital Market | ||
|
Guardant Health
GH
|
$ 101.73 | -0.4 % | $ 12.5 B | Nasdaq Global Select Market,SPB | ||
|
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | ||
|
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
IQVIA Holdings
IQV
|
$ 225.49 | 0.08 % | $ 40.9 B | NYSE,SPB | ||
|
Illumina
ILMN
|
$ 134.02 | 2.18 % | $ 21.3 B | Nasdaq Global Select Market,SPB | ||
|
Charles River Laboratories International
CRL
|
$ 201.62 | 1.09 % | $ 10.4 B | NYSE,SPB | ||
|
OPKO Health
OPK
|
$ 1.3 | 2.78 % | $ 902 M | Nasdaq Global Select Market | ||
|
Quest Diagnostics Incorporated
DGX
|
$ 173.33 | -0.05 % | $ 19.2 B | NYSE,SPB | ||
|
Biodesix
BDSX
|
$ 6.37 | -6.32 % | $ 826 M | Nasdaq Global Market | ||
|
Koninklijke Philips N.V.
PHG
|
$ 27.15 | 0.22 % | $ 20 B | NYSE | ||
|
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | ||
|
ICON Public Limited Company
ICLR
|
$ 187.85 | 3.09 % | $ 15.5 B | Nasdaq Global Select Market,SPB | ||
|
IDEXX Laboratories
IDXX
|
$ 671.36 | -0.76 % | $ 55.4 B | Nasdaq Global Select Market,SPB | ||
|
Lantheus Holdings
LNTH
|
$ 67.25 | 1.05 % | $ 4.65 B | Nasdaq Global Select Market,SPB | ||
|
Agilent Technologies
A
|
$ 137.32 | 0.87 % | $ 41.7 B | NYSE,SPB | ||
|
Mettler-Toledo International
MTD
|
$ 1 409.97 | 1.13 % | $ 29.9 B | NYSE,SPB | ||
|
Organovo Holdings
ONVO
|
- | -2.3 % | $ 19.4 M | Nasdaq Capital Market | ||
|
Personalis
PSNL
|
$ 7.85 | -1.44 % | $ 465 M | Nasdaq Global Select Market | ||
|
Biomerica
BMRA
|
$ 2.51 | -0.39 % | $ 5.77 M | Nasdaq Capital Market | ||
|
Bioventus
BVS
|
$ 7.23 | -2.82 % | $ 453 M | Nasdaq Global Select Market | ||
|
Myriad Genetics
MYGN
|
$ 6.18 | 0.41 % | $ 560 M | Nasdaq Global Select Market,SPB | ||
|
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.